If money was the only reason, wouldnt a big pharma have come after NZ-2591 already? I guess it is possible that Neuren was still unproven when these trials were conducted, so the larger parties weren't interested back then. I dont know how the big pharma industry really works, so just wondering what it takes for them to become interested in a product. If the current phase 2 trials prove successful, then these other earlier successful animal trials surely would all come into play?
So our 'partnering' deals wouldn't necessarily be limited to these 4 trials only.....?
If money was the only reason, wouldnt a big pharma have come...
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.48 |
Change
0.160(1.04%) |
Mkt cap ! $1.978B | |||
| Open | High | Low | Value | Volume |
| $15.10 | $15.48 | $15.04 | $6.154M | 402.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1498 | $15.45 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.50 | 8296 | 2 |
View Market Depth
| Last trade - 16.10pm 21/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |